Just launched · October 2026—Rankings get sharper with every edition.Spotted an error?Tell us →
Sign in / Register

Harpe Bioherbicide Solutions

Active#25 worldwide · Biological inputs

Develops plant-based natural herbicides and premix formulations for row and specialty crops, targeting hard-to-control weeds including herbicide-resistant species.

HQUnited States
Last roundFunding round · Apr 2023

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Biological inputs · worldwideTop 32#25Edition 0 · Oct 202612 Feb 2027
Rank historyOct 2026 · #25 Biological inputsFirst edition: no movements yet.

Estimated valuation

AI · Biological inputs ranking (worldwide)
≈ USD 54MUSD 36–81M · Tens of M$
Anchor
Last known equity round: Funding round · USD 10.5M · Apr 2023

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

DateRoundAmountTypeInvestors
Apr 2023Funding roundUSD 10.5MEquityADM, iSelect, Alexandria Venture Investments

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Harpe Bioherbicide Solutions as a PDF. It must answer at least one of these four questions, and stick to them:

AI valuation: $54MUndervalued or overvalued?
Versus competitorsHow does it compare?
Who should acquire itStrategic buyers, and why
Who should it acquireAcquisition targets, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Comparable companies in biological inputs

Full biological inputs ranking →

Investors in Harpe Bioherbicide Solutions: ADM · iSelect · Alexandria Venture Investments

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.